Pharma 4.0 & Fill-Finish — Damgaard Solutions
Foundation

Pharma 4.0 is an engineering problem, not a software one.

Most digital transformation projects in pharma stall because the technology vendor does not understand GMP and the GMP consultant does not understand the technology. We sit at the intersection. Senior engineers who have validated aseptic fill-finish lines and built digital maturity roadmaps for commercial manufacturing. Same people. Same engagement.

You get one team that can move from URS to digital twin to PPQ without translating between disciplines. No handoff gaps. No "that is not my scope" conversations when a data integrity issue shows up in the middle of a CQV cycle.

  • Digital maturity assessment tied to your actual regulatory roadmap
  • Data integrity strategy built into the validation approach
  • PAT and real-time release design that matches your QC reality
Pharmaceutical facility with smart manufacturing equipment
Fill-finish equipment integration close-up
Fill-Finish Integration

Your line, integrated. Your team, capable.

Aseptic fill-finish lines carry the highest regulatory stakes in pharma manufacturing. They also carry the highest complexity when digitisation arrives. Isolator controls, vision inspection, line automation, packaging integration, data flow to your QMS. Each system GMP-critical. Each interface a potential compliance gap.

We map the full integration, design the validation approach, and teach your team to own it. The Scandinavian model. When we leave, your operators understand the system. Your QA team has the documentation. Your engineering group has the design rationale. Nothing walks out the door with the consultant.

  • Line integration scoping with phased CapEx and OpEx modelling
  • Capability transfer built into every milestone, not sold separately
  • Fixed-fee per stage. You approve each gate before the next begins
Validation

Audit-ready from the first line of code.

Digital systems in GMP environments need the same validation rigour as physical ones. URS, IQ/OQ/PQ, change control, data integrity. The regulator will not accept "the software vendor handles that." We write the validation package that holds up to EU GMP Annex 11, FDA 21 CFR Part 11, and whatever comes next.

Every engagement produces a structured knowledge package for your internal team. SOPs, validation protocols, system design rationale, change control framework. Documented the way your next inspection will need to read it. The way your next hire will need to learn from it.

  • Annex 11 and 21 CFR Part 11 validation built into scope, not added at the end
  • Complete documentation package handed to your team, not retained by us
  • Post-go-live support structured as transferable capability, not a retainer trap
Pharmaceutical manufacturing facility interior

Ready to digitise without the validation scramble?

Send us a brief. Even a rough one. We respond within 24 hours with a named specialist and an honest assessment of what your digital maturity actually requires.